CCM
FLACU

Context Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Context Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-121,326
Closed -$1.2M – 913
2021
Q4 		$1.2M Hold
121,326
– – 0.09% 264
2021
Q3 		$1.22M Hold
121,326
– – 0.12% 201
2021
Q2 		$1.22M Hold
121,326
– – 0.11% 206
2021
Q1 		$1.23M Hold
121,326
– – 0.12% 193
2020
Q4 		$1.26M Buy
+121,326
New +$1.27M 0.17% 124

Other funds holding FLACU

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Context Capital Management's FLACU Position: Q1 2022 in Review

Context Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q1 2022, closing a stake of 121,326 shares — an estimated $1.2M sold.

Context Capital Management first reported a position in FLACU in Q4 2020 and held it in 5 quarters. The position peaked at $1.26M in Q4 2020. 21 funds tracked by Wall St. Rank hold FLACU as of Q1 2022.

  • Context Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Context Capital Management sold 121,326 Frazier Lifesciences Acquisition Corporation Unit shares in Q1 2022, an estimated $1.2M.
  • Context Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 5 quarters.
  • Context Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $1.26M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q1 2022.

Based on Context Capital Management's 13F filing for Q1 2022, filed 9 May 2022.